OUR SOLUTION
BrainScore-coma is intended to reduce uncertainty in the comatose patient care
BrainScore-coma is a software module of BrainTale-care platform for the provision of a neurologic prediction score related to comatose patient outcome based on diffusion regional standardized parameters from brain diffusion MRI images obtained from brainQuant. It is dedicated to comatose patients aged 18 or more, unconscious on day 7 after cardiac arrest1 and on day 5 after traumatic brain injury2.
1 : Velly L et al., Use of brain diffusion tensor imaging for the prediction of long-term neurological outcomes in patients after cardiac arrest: a multicentre, international, prospective, observational, cohort study. Lancet Neurol. 2018 Apr;17(4):317-326. doi: 10.1016/S1474-4422(18)30027-9
2 : Puybasset L et al., Prognostic value of global deep white matter DTI metrics for 1-year outcome prediction in ICU traumatic brain injury patients: an MRI-COMA and CENTER-TBI combined study. Intensive Care Med. 2022 Feb;48(2):201-212. doi: 10.1007/s00134-021-06583-z
Legal mentions
BrainScore-coma is a class IIa Medical Device CE-marked. Conformity assessment carried out by the notified body BSI. BSI certification 2797.
For trained users only, read carefully the instructions and the labelling before use.
Intended for health professionals, not reimbursable by health insurance organization.
BRAINTALE, whose head office is 11 rue de l’Académie 67000 – STRASBOURG, is registered in the Trade and Companies Register under number 840 995 138 RCS STRASBOURG
Last update : 11/25/2022